FGF21 resistance is not mediated by downregulation of beta-klotho expression in white adipose tissue

Kathleen R Markan1,2, Meghan C Naber1,2, Sarah M Small1,2

  • 1Department of Pharmacology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA.

Abstract

Insights

Fibroblast growth factor 21 (FGF21) resistance in obesity is not primarily caused by reduced β-klotho in white adipose tissue. Maintaining β-klotho levels did not restore FGF21 sensitivity in vivo.

Area of Science:

  • Metabolic homeostasis and endocrine signaling

Background:

  • Fibroblast growth factor 21 (FGF21) regulates metabolic homeostasis.
  • Diet-induced obesity can lead to FGF21 resistance, potentially due to decreased co-receptor β-klotho in adipose tissue.

Purpose of the Study:

  • To investigate if maintaining β-klotho expression in adipose tissue prevents FGF21 resistance.
  • To explore other mechanisms contributing to FGF21 resistance in vivo.

Main Methods:

  • Generation of adipose-specific β-klotho transgenic mice.
  • Assessment of FGF21 signaling and sensitivity in vivo.

Main Results:

  • White adipose tissue showed decreased β-klotho protein during diet-induced obesity, unlike liver or brown adipose tissue.
  • Maintaining adipose β-klotho did not improve FGF21 signaling or sensitivity in white adipose tissue.

Conclusions:

  • Reduced β-klotho expression is not the primary driver of impaired FGF21 signaling in white adipose tissue during obesity.
  • Other mechanisms contribute to FGF21 resistance.